Bridge 2026 - Building relationships to innovate and develop globalexpertise in cardiovascular medicine - 2nd edition
Congresso internazionale RES di cardiologia e chirurgia cardiovascolare (2ª ed.): cardio-renale-metabolico, dislipidemie, ipertensione, sindromi coronariche, valvola aortica e chirurgia dell'arco aortico, al Policlinico Gemelli.
Provider
Event LabEvent Lab (6364)
Crediti ECM
11
Costo
Gratuito
Durata
11 ore
Date
25 - 26 set '26
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.
Razionale scientifico
BRIDGE 2026 – Building Relationships to Innovate and Develop Global Expertise in Cardiovascular Medicine – Second Edition was conceived as a dynamic forum designed to foster interdisciplinary collaboration, clinical innovation, and the advancement of personalized cardiovascular care. As the global burden of cardiovascular disease continues to rise, there is a pressing need to move beyond traditional paradigms and integrate novel diagnostic, therapeutic, and organizational strategies into everyday practice. Now in its second edition, BRIDGE 2026 builds on the success of its inaugural meeting by addressing four major pillars of cardiovascular disease, cardiac and vascular surgery, through a comprehensive and highly interactive format that includes case-based discussions, cutting-edge lectures, and multidisciplinary panels. The active participation of residents and young clinicians in presenting complex clinical cases reflects the program's strong commitment to mentorship, education, and the continuous renewal of medical expertise. At the core of BRIDGE 2026 lies the principle of value-based healthcare, which prioritizes outcomes that matter most to patients, balanced with the resources required to achieve them. In cardiovascular medicine, this translates to delivering care that improves survival, function, and quality of life, while ensuring sustainability, efficiency, and equity across healthcare systems. Value is created not only through innovative diagnostics and therapies, but also through coordinated, patient-centered pathways that enhance continuity and integration of care. A central focus of this year's edition is the promotion of transversal management, emphasizing the need for seamless integration across specialties, disciplines, and care settings. Cardiovascular patients often present with complex, multi-system conditions requiring a unified clinical vision and synchronized therapeutic strategies. By exploring real-world approaches such as hybrid revascularization, emerging biomarkers, novel risk stratification methods, and cutting-edge pharmacological innovations, the agenda highlights how teamwork and multidimensional care planning can translate into improved patient outcomes. BRIDGE 2026 is more than a scientific event: it is a shared space to bridge the gaps—between acute and chronic care, between disciplines, and between research and clinical practice—reimagining cardiovascular medicine through the lens of value, integration, and human-centered innovation.
Luogo
Policlinico Universitario A. Gemelli, L.Go A. Gemelli 8 - Roma, Roma, Roma, Lazio
Programma
- 08:15–08:45Registration
- 08:45–09:00Institutional Greetings, Opening Remarks and Welcome AddressAlessandro Sgambato, Daniele Piacentini, Antonio Gasbarrini, Ignazio R. M. Marino, Massimo Massetti
- 09:00–09:30Opening Lecture: Bridging Coronary Atherothrombosis and Colorectal Carcinogenesis Through Platelet Inhibition: Aspirin in its 130th Year of LifeCarlo Patrono
- 09:40–09:50The dangerous connection between diabetes, cardiovascular disease, and kidney healthErnesto Maddaloni
- 09:50–10:00The dangerous intersection of diabetes and peripheral artery diseaseFederico Biscetti
- 10:00–10:10More than weight control: the cardiorenal promise of GIP/GLP-1 RAsGertrude Mingrone
- 10:10–10:20Sodium-glucose cotransporter 2 inhibitors for chronic kidney disease: why, when and when notGiuseppe Grandaliano
- 10:20–10:30Redefining cardiovascular protection in patients with or without diabetes: the expanding role of SGLT2 inhibitorsRosa Lillo
- 10:30–10:40Next-generation aldosterone blockers: finerenone for cardiorenal protectionMario Canonico
- 10:40–10:50The central role of general practitioners in cardio-renal-metabolic care: PDTA as a catalyst for integrationMaurizio Ridolfi
- 10:50–11:10Keynote Lecture: Cardio-renal-metabolic disease management: moving from treat-to-target to treat-to-benefitGiorgio Sesti
- 11:10–11:25Roundtable discussion and Q&A with all speakers
- 11:25–11:55Coffee Break and Networking
- 11:55–12:05Lipid-lowering therapy after the ESC 2025 guidelines: the role of statins and statin-ezetimibe combinationsGiorgia Polito
- 12:05–12:15Advancing cardiovascular prevention: the emerging role of bempedoic acidLuca Moriconi
- 12:15–12:25From discovery to clinical practice: PCSK9 inhibitors as a paradigm of translational research in cardiovascular preventionMaria Margherita Rando
- 12:25–12:35From gene silencing to clinical practice: why Inclisiran represents a durable and reliable therapeutic optionLeonardo De Luca
- 12:35–12:45Triglyceride level as a potential marker of residual cardiovascular riskMatteo Pirro
- 12:45–13:05Keynote Lecture (Remote): Lipoprotein(a): a key driver of residual cardiovascular risk and the promise of novel pharmacological therapiesMarc P. Bonaca
- 13:05–13:20Roundtable discussion and Q&A with all speakers
- 13:20–14:30Lunch Break
- 14:30–14:40ESC Guidelines 2024: the impact of new targets in cardiovascular care — bridging evidence and clinical practiceMichele Santoro
- 14:40–14:50Single pill or polypills: can adherence be improved?Claudio Santini
- 14:50–15:00The growing problem of resistant hypertensionGiuliano Tocci
- 15:00–15:10Cardiac Amyloidosis and left ventricular hypertrophy as drivers of heart failure with preserved ejection fractionFrancesca Graziani
- 15:10–15:20Renal denervation in hypertension management: an alternative or a complement to pharmacological therapy?Roberto Iezzi
- 15:20–15:40Keynote Lecture: Hypertension and aging: clinical realities, research innovations, and the road aheadGiovambattista Desideri
- 15:40–15:55Roundtable discussion and Q&A with all speakers
- 15:55–16:30Coffee Break and Networking
- 16:30–16:40The acute cardiovascular patient: toward precision management in acute coronary syndromesGregary Marhefka
- 16:40–16:50Cardiogenic shock complicating acute myocardial infarction: current challenges and emerging strategiesTommaso Sanna
- 16:50–17:00High-Risk PCI in acute coronary syndromes: the expanding role of mechanical circulatory supportCristina Aurigemma
- 17:00–17:10Beyond angiography: functional and intracoronary imaging assessment of intermediate coronary lesionsAntonio Maria Leone
- 17:10–17:20Inflammation and residual risk after acute coronary syndromes: implications for future therapiesGiovanna Liuzzo
- 17:20–17:40Keynote Lecture: Ischemic heart disease beyond obstructive coronary disease: a new clinical paradigmPaolo Camici
- 17:40–17:55Roundtable discussion and Q&A with all speakers
- 17:55–18:15Conclusions first day
Responsabili del corso
EVENT LAB
Provider
ID Provider: N° 6364
Città: Roma (RM)
Tipologia: Società, Agenzie Ed Enti Privati
Stato accreditamento: Standard
Andrea Flex
Responsabile scientifico
Specializzazione: Medicina Interna; Cardiochirurgia
Struttura: Università Cattolica del Sacro Cuore Roma
Ruolo: Direttore Medicina Cardiovascolare
Massimo Massetti
Responsabile scientifico
Specializzazione: Cardiochirurgia
Struttura: Policlinico Gemelli Roma
Ruolo: Chief of Cardiac Surgery; Chair Department of Cardiovascular Sciences CUORE
Yamume Tshomba
Responsabile scientifico
Specializzazione: Chirurgia Vascolare
Struttura: Università Cattolica del Sacro Cuore Roma
Ruolo: Chief of Vascular Surgery
Relatori e docenti
Rene J. Alvarez
Moderatore
Specializzazione: Cardiologia
Struttura: Jefferson Health, Philadelphia USA
Ruolo: Professor of Cardiology
Cristina Aurigemma
Relatore
Specializzazione: Cardiologia
Struttura: Policlinico Gemelli Roma
Ruolo: Dirigente Medico Unità Cardiologia Interventistica
Federico Biscetti
Relatore
Specializzazione: Chirurgia Vascolare
Struttura: Policlinico Gemelli Roma
Ruolo: CUORE Cardiovascular Unique Offer Re-Engeneered
Marc P. Bonaca
Relatore
Specializzazione: Cardiologia
Struttura: UC Health Heart and Vascular Center, Aurora Colorado
Ruolo: Executive Director of Cardiological Clinical Research
Ottavia Borghese
Relatore
Specializzazione: Chirurgia Vascolare
Struttura: Policlinico Gemelli Roma
Ruolo: Dirigente Medico Chirurgia Vascolare
Con il contributo non vincolante di
- AMGEN
- ASTRAZENECA
- BAYER
- FENICIA EVENTS
- DAIICHI SANKYO
Domande frequenti
Questo evento è accreditato per: Medico Chirurgo (Geriatria, Chirurgia Vascolare, Cardiochirurgia, Cardiologia, Medicina Interna, Malattie Metaboliche E Diabetologia).
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.